30.10.2012 Views

Presidential Greeting - American Society for Laser Medicine and ...

Presidential Greeting - American Society for Laser Medicine and ...

Presidential Greeting - American Society for Laser Medicine and ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

52 <strong>American</strong> <strong>Society</strong> <strong>for</strong> <strong>Laser</strong> <strong>Medicine</strong> <strong>and</strong> Surgery Abstracts<br />

unblinded evaluation PDT reactions were enhanced <strong>and</strong> clearance<br />

rates increased on the treated extremity compared to the nontreated<br />

extremity. The treatment was generally tolerated well.<br />

Conclusion: Warm-skin PDT appears to improve the efficacy of<br />

the treatment of actinic keratoses on the extremities with<br />

reasonable tolerability <strong>and</strong> may be a useful adjunct in the setting<br />

of field cancerization.<br />

#177<br />

FRACTIONAL CO2 LASER IMPROVES<br />

TREATMENT OF NBCC WITH ALA-PDT<br />

Roman Smucler, Jan Lippert, Marek Vlk<br />

Charles University, Prague, Czech Republic<br />

Background: Photodynamic therapy with aminolevulic acid<br />

(ALA-PDT) is well-established treatment method <strong>for</strong> superficial<br />

<strong>for</strong>m of basal cell carcinoma (BCC) <strong>and</strong> actinic keratosis mostly.<br />

Nodular <strong>for</strong>m of BCC is perceived as contraindication due to<br />

tumor layer bigger then 2 mm. Proper penetration of<br />

photosensitizer is crucial. Classical approach is curettage.<br />

Authors previously improved results with ablative laser. Another<br />

possibility offers ablative fractional laser which produce skin<br />

microtubules. This principle can enhance penetration of ALA but<br />

necrotic tissue surrounding tubules can decrease effectiveness.<br />

Aim of our study is to evaluate fractional laser as pre-treatment<br />

be<strong>for</strong>e ALA-PDT in nodular BCC.<br />

Study: Twenty-five histologically verified nBCC were under<br />

control of ultrasound ablated with 980 nm diode laser up depth<br />

between 1 <strong>and</strong> 3 mm. Three weeks later half of tumor was treated<br />

with curettage <strong>and</strong> second with fractional CO2 laser—density<br />

40%. Study was blinded with different side treatment.<br />

Immediately after we applied mALA, 3 hours occlusion, Aklilite<br />

irradiation 40 J cm 2 . Checkups every months with fluorescence<br />

(ALA based) <strong>and</strong> defined photography. Single-blinded. Evaluator<br />

compared fluorescence with use of scale. After 12 months biopsy<br />

from both sides.<br />

Results: Twenty-five nBCC treated compare 22 in control<br />

group. Fluorescence significantly lower in treatment group. More<br />

adverse effects <strong>and</strong> longer down time in treatment group.<br />

Conclusion: Fractional laser pre-treatment can enhance ALA-<br />

PDT but we do not know proper parameters, optimal laser, protocol.<br />

Many studies will be necessary be<strong>for</strong>e finalclinicaloutcomes.<br />

#178<br />

NEW TOPICAL PHOTODYNAMIC THERAPY FOR<br />

MANAGEMENT OF PRIMARY AXILLARY<br />

HYPERHIDROSIS<br />

Abeer Attia, Manal Salah<br />

National Institute of Enhanced <strong>Laser</strong> Sciences, Cairo, Egypt<br />

Background: A variety of treatment modalities have been used<br />

in the management of primary axillary hyperhidrosis but no ideal<br />

treatment yet. Recurrence <strong>and</strong> side effects of these modalities<br />

suggested the need <strong>for</strong> a long acting treatment with a strong<br />

safety profile. To study the efficacy <strong>and</strong> safety of photodynamic<br />

therapy in management of primary axillary hyperhidrosis using<br />

topical Eosin gel <strong>and</strong> intense pulsed light.<br />

Study: Twenty patients were treated using intense pulsed light<br />

with a 400 nm filter, 20 milliseconds pulse duration <strong>and</strong> 25 J/cm 2<br />

fluence, once weekly, <strong>for</strong> four sessions after applying Eosin gel to<br />

the right axilla <strong>for</strong> 1 hour <strong>and</strong> placebo gel to the left. Efficacy was<br />

measured by hyperhidrosis disease severity scale (HDSS), <strong>and</strong><br />

assessment of sweating area reduction using the minor iodine<br />

starch test. Liposomal eosin hydrogel has been prepared <strong>and</strong><br />

applied on 24 rats to test <strong>for</strong> sensitivity reaction, <strong>and</strong> autopsies<br />

were examined histologically after irradiation of liposomal Eosin<br />

hydrogel with light emitting diode (LED).<br />

Results: A highly significant reduction of the mean hyperhidrotic<br />

area from 65 28.2 cm 2 be<strong>for</strong>e treatment to 5.7 5.2 cm 2 at the<br />

end of treatment (P < 0.01). A 90.1% reduction in the area of<br />

hyperhidrosis of the right axilla was obtained versus 2.2%<br />

reduction in the placebo site. A 3-point improvement on the 4point<br />

(HDSS) was reported in seven patients (35%), a 2-point<br />

improvement was reported in nine patients (45%) <strong>and</strong> 1-point<br />

improvement was elicited in four patients (20%). Three patients<br />

(15%) reported a 1-point improvement from HDSS score 4 to score<br />

3 at the placebo site. No recurrence occurred during the 8-month<br />

follow-up period.<br />

Conclusion: Photodynamic therapy using Eosin gel, which is<br />

photoactivated by IPL, is a non-invasive, safe <strong>and</strong> effective<br />

method <strong>for</strong> management of primary axillary hyperhidrosis with<br />

no risk of multiple frequent injections <strong>and</strong> is not time consuming.<br />

Further studies <strong>and</strong> long-term follow-up are needed.<br />

#179<br />

INVESTIGATION OF THE EFFECTIVENESS OF<br />

NON-COHERENT BLUE LIGHT IN<br />

INTRALESIONAL PHOTODYNAMIC THERAPY OF<br />

BASAL CELL CARCINOMA<br />

Robert Anolik, Lori Brightman, Anne Chapas,<br />

Elliot Weiss, Leonard Bernstein, Roy G. Geronemus,<br />

Elizabeth K. Hale, Julie K. Karen<br />

<strong>Laser</strong> <strong>and</strong> Skin Surgery Center of New York, New York, NY<br />

Background: Innovative treatments are urgently needed <strong>for</strong> the<br />

more than 1 million non-melanoma skin cancers (NMSCs) that<br />

arise in the US annually, particularly <strong>for</strong> those prone to numerous<br />

NMSCs or poor surgical c<strong>and</strong>idates. Topical photodynamic<br />

therapy (PDT) offers a novel strategy. Injection of<br />

photosensitizing agents may enhance PDT efficacy by increasing<br />

depth of activity around localized tumors. The purpose of this<br />

study is to determine the effectiveness of non-coherent blue light<br />

in the intralesional PDT of BCC.<br />

Study: This is a prospective, IRB-approved study of 20 BCCs in a<br />

private dermatology center. Each BCC was injected with 20%<br />

aminolevulinic acid, incubated <strong>for</strong> one hour, <strong>and</strong> exposed to noncoherent<br />

blue light. If without clinical clearance at 8 weeks, a<br />

second treatment was per<strong>for</strong>med. Clinical evaluations were<br />

per<strong>for</strong>med at each treatment <strong>and</strong> repeated at 16 weeks, 1 year,<br />

<strong>and</strong> 2 years after PDT. These follow-up visits included subjective<br />

patient assessments <strong>and</strong> punch biopsies of the treatment sites.<br />

Results: To date, no patient has been lost to follow-up. All 20<br />

BCCs were evaluated at 16 weeks, showing recurrence at two sites<br />

on histology. For those 18 sites still negative at 16 weeks, 13 have<br />

been re-evaluated at 1 year, with an additional 4 sites of<br />

recurrence. Five have returned <strong>for</strong> their 2-year exam <strong>and</strong> showed<br />

recurrence at 1 more site. Although the number may increase with<br />

the remaining 1- <strong>and</strong> 2-year follow-up visits, the overall<br />

recurrence rate to date is 35% (7 of 20 sites) at 2 years. Notably,<br />

physicians graded cosmetic outcome as good-to-excellent in 2/3 or<br />

more of the treatment sites at all follow-up exams. No unusual<br />

adverse event was appreciated.<br />

Conclusion: Intralesional PDT offers a potential alternative <strong>for</strong><br />

effective <strong>and</strong> cosmetically acceptable treatment of BCC, although<br />

recurrence rates are higher than some other options.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!